Journal of Medicinal Chemistry · 2015 · 42 citations · 30 references
Life SciencesMedicinal ChemistryPharmacologyApoptosisAutophagyStructure-activity RelationshipsAutophagy In CancerAutophagy ModulationAutophagy Signaling PathwaysBcl-2 Family ProteinsLead Compound DesignStructure-activity Relationship AnalysisAnti-apoptotic AgentsAnticancer ActivityAutophagy InhibitionAutophagy PathwayAutophagy-targeting DrugsCytotoxicity AssaysMedicinal Chemistry ApplicationsStereochemical Structure - Activity Relationship
Sclareol, a promising anticancer labdane diterpene, was isolated from Salvia sclarea. Keeping the basic stereochemistry-rich framework of the molecule intact, a method for the synthesis of novel sclareol analogues was designed using palladium(II)-catalyzed oxidative Heck coupling reaction in order to study their structure-activity relationship. Both sclareol and its derivatives showed an interesting cytotoxicity profile, with 15-(4-fluorophenyl)sclareol (SS-12) as the most potent analogue, having IC50 = 0.082 μM against PC-3 cells. It was found that SS-12 commonly interacts with Bcl-2 and Beclin 1 BH3 domain proteins and enhances autophagic flux by modulating autophagy-related proteins. Moreover, inhibition of autophagy by autophagy inhibitors protected against SS-12-induced apoptosis. Finally, SS-12 effectively suppressed tumor growth in vivo in Ehrlich's ascitic and solid Sarcoma-180 mouse models.
30